Fracture risk assessment: State of the art, methodologically unsound, or poorly reported?

Gary S. Collins*, Karl Michaëlsson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Osteoporotic fractures, including hip fractures, are a global health concern associated with significant morbidity and mortality as well as a major economic burden. Identifying individuals who are at an increased risk of osteoporotic fracture is an important challenge to be resolved. Recently, multivariable prediction tools have been developed to assist clinicians in the management of their patients by calculating their 10-year risk of fracture (FRAX, QFracture, Garvan) using a combination of known risk factors. These prediction models have revolutionized the way clinicians assess the risk of fracture. Studies evaluating the performance of prediction models in this and other areas of medicine have, however, been characterized by poor design, methodological conduct, and reporting. We examine recently developed fracture prediction models and critically discuss issues in their design, validation, and transparency.

Original languageEnglish
Pages (from-to)199-207
Number of pages9
JournalCurrent Osteoporosis Reports
Volume10
Issue number3
DOIs
Publication statusPublished - Sept 2012

Keywords

  • Calibration
  • Clinical prediction models
  • Discrimination
  • Fracture risk assessment
  • FRAX
  • Garvan
  • Hip fracture
  • Osteoporosis
  • QFracture
  • Validation

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Fingerprint

Dive into the research topics of 'Fracture risk assessment: State of the art, methodologically unsound, or poorly reported?'. Together they form a unique fingerprint.

Cite this